Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.46 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.46 |
| ▸ | TSHR | P16473 | 3/20 | 0.42 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.37 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.33 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.33 |
| ▸ | HIF1A | Q16665 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10714767 | 0.78 | ALDH1A1 (0.44) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 | |
| SCHEMBL27715552 | 0.75 | ALDH1A1 (0.46) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL1621552 | 0.75 | ALDH1A1 (0.42) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 | |
| SCHEMBL1169404 | 0.75 | ALDH1A1 (0.33) | ALDH1A1L3MBTL1ALOX15 | |
| Pivalate SCHEMBL28392338 | 0.73 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 | |
| SCHEMBL1622163 | 0.73 | ALDH1A1 (0.40) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 | |
| SCHEMBL2373498 | 0.73 | ALDH1A1 (0.47) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL28144774 | 0.73 | TSHR (0.40) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 | |
| SCHEMBL6632023 | 0.73 | ALDH1A1 (0.43) | ALDH1A1L3MBTL1TSHRCYP2D6CYP2C19 | |
| SCHEMBL3989015 | 0.73 | BLM (0.32) | ALDH1A1L3MBTL1TSHRALOX15CYP2D6 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 104 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-2622016-B1 | ENERGY RECOVERY VENTILATION SULFONATED BLOCK COPOLYMER LAMINATE MEMBRANE | KRATON POLYMERS US LLC (US) | 2023-06-07 | — | — | EP | disclosed |
| CN-108884055-B | Pyridazinone compound or salt thereof, and herbicide containing same | 石原产业株式会社 | 2022-07-12 | — | — | CN | disclosed |
| US-11021559-B2 | Sulfonated block copolymer laminates with polar or active metal substrates | KRATON POLYMERS LLC (US) | 2021-06-01 | — | — | US | disclosed |
| US-20210010759-A1 | ENHANCED-EFFICIENCY ENERGY RECOVERY VENTILATION CORE | KRATON POLYMERS LLC (US) | 2021-01-14 | — | — | US | disclosed |
| CN-112137995-A | Methods and mixtures for increasing the cellular availability of calcium in skin cells | 默克专利股份有限公司 | 2020-12-29 | — | — | CN | disclosed |
| US-20200071447-A1 | Sulfonated Block Copolymer Laminates with Polar or Active Metal Substrates | KRATON POLYMERS LLC (US) | 2020-03-05 | — | — | US | disclosed |
| CN-110730820-A | Aldehyde dehydrogenase variants and methods of use | 基因组股份公司 | 2020-01-24 | — | — | CN | disclosed |
| CN-110691847-A | 3-hydroxybutyryl-CoA dehydrogenase variants and methods of use | 基因组股份公司 | 2020-01-14 | — | — | CN | disclosed |
| EP-2893281-B1 | ENHANCED-EFFICIENCY ENERGY RECOVERY VENTILATION CORE | KRATON POLYMERS US LLC (US) | 2019-10-02 | — | — | EP | disclosed |
| EP-2943514-B1 | ANION EXCHANGE BLOCK COPOLYMERS, THEIR MANUFACTURE AND THEIR USE | KRATON POLYMERS US LLC (US) | 2019-06-05 | — | — | EP | disclosed |
| WO-2009089541-A2 | A NEW INHIBITOR SCAFFOLD FOR THE INHIBITION OF THE ENZYME PHOSPHOENOLPYRUVATE CARBOXYKINASE | UNIVERSITY OF KANSAS (US) | 2009-07-16 | — | — | WO | disclosed |
| US-7517875-B2 | Piperidine derivatives having CCR3 antagonism | TEIJIN LIMITED (JP) | 2009-04-14 | — | — | US | disclosed |
| WO-2008089332-A2 | METHOD OF SULFONATION OF BLOCK POLYMERS | STEPAN COMPANY (US) | 2008-07-24 | — | — | WO | disclosed |
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | TEIJIN LIMITED, A JAPANESE BODY CORPORATE (JP) | 2007-02-08 | — | — | US | disclosed |
| EP-1502916-A1 | PIPERIDINE DERIVATIVES HAVING CCR3 ANTAGONISM | TEIJIN LIMITED (JP) | 2005-02-02 | — | — | EP | disclosed |
| US-6583250-B2 | Particularly to cyanoacrylate adhesives, by mixing in a polymerization initiator capable of initiating polymerization of the monomers of the adhesive, at a temperature above the polyolefin's glass transition temperature | HENKEL KOMMANDITGESELLSCHAFT AUF AKTIEN (DE) | 2003-06-24 | — | — | US | disclosed |
| CN-1096448-C | Farnesyl transferase inhibitors, its preparation and medicine composition thereof | RHONE POULENC RORER SA (FR) | 2002-12-18 | — | — | CN | disclosed |
| US-20010009954-A1 | POLYOLEFINE MATERIALS WITH IMPROVED ADHESIVITY | COGNIS DEUTSCHLAND GMBH & CO. KG (DE) | 2001-07-26 | — | — | US | disclosed |
| CN-1190389-A | Novel farnesyl transferase inhibitors, process for their preparation and pharmaceutical compositions containing them | RHONE POULENC RORER SA (FR) | 1998-08-12 | — | — | CN | disclosed |
| US-4601904-A | Antibiotics xylocandin A and xylocandin B | E. R. SQUIBB & SONS, INC. (US) | 1986-07-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070032525-A1 | Piperidine derivatives having ccr3 antagonism | CCR3, CCR1, CCR4 | ALDH1A1 451/4885L3MBTL1 3446/4885TSHR 3393/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.